Virginia National Bank Danaher Corp Transaction History

Virginia National Bank

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	SELL	$237.11 - $299.66 $47,896 - $60,531	-202 Reduced 12.55%	1,407 $357,000
Q1 2022 Apr 27, 2022	BUY	$257.27 - $315.76 $413,947 - $508,057	1,609 New	1,609 $472,000
Q1 2020 Apr 17, 2020	SELL	$121.39 - $169.05 $273,977 - $381,545	-2,257 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$133.47 - $153.48 $415,625 - $477,936	-3,114 Reduced 57.98%	2,257 $347,000
Q3 2019 Oct 16, 2019	SELL	$135.4 - $146.47 $1,083 - $1,171	-8 Reduced 0.15%	5,371 $776,000
Q2 2019 Jul 08, 2019	SELL	$124.88 - $143.73 $1,998 - $2,299	-16 Reduced 0.3%	5,379 $769,000
Q4 2018 Jan 24, 2019	SELL	$94.85 - $109.54 $474 - $547	-5 Reduced 0.09%	5,395 $556,000
Q3 2018 Nov 15, 2018	BUY	$98.13 - $108.9 $529,902 - $588,060	5,400 New	5,400 $587,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Virginia National Bank, based on Form 13F filings with the SEC.

Stay updated on Virginia National Bank with notifications on news.